Cases of severe cutaneous adverse reactions, including Stevens-Johnsons syndrome (SJS) and toxic epidermal necrolysis (TEN), have been reported in patients treated with immune-stimulatory anti-cancer drugs, including atezolizumab. Advise patients to be vigilant for the signs of severe skin reactions and to seek urgent medical advice if they occur.
- Read more about Atezolizumab and other immune-stimulatory anti-cancer drugs: risk of severe cutaneous adverse reactions
- Log in or register to post comments
source https://www.pharmatutor.org/content/pharmapedia/atezolizumab-and-other-immune-stimulatory-anti-cancer-drugs-risk-of-severe-cutaneous-adverse-reactions
No comments:
Post a Comment